Hallucinogens as treatment for PTSD, anxiety and depression
20 July 2020
Overview
The aim of this rapid evidence assessment (REA) was to assess the evidence related to hallucinogenic drug interventions for PTSD, anxiety, and depression in adults.
Documents in this publication
Download a copy of the documents below.
